Literature DB >> 23105912

Cerebro-spinal and renal ochronosis: A rare case report.

Sunil Kumar Nanda1, D R Suresh, A Vamseedhar, K Pratibha, B Arjun.   

Abstract

Alkaptonuria, a rare inborn error of tyrosine metabolism, characterized by the absence of homogentisic acid oxidase results in the accumulation of homogentisic acid in the body. Associated renal failure and cerebral infarction is rare and usually occurs in the later stages of the disease. We report a 55-year-old male who presented, initially with features of stroke and degenerative arthritis. He had pigmentation of sclerae, darkening of urine on long standing, abnormal renal profile, degenerative arthritis and cerebral infarction. Alkaptonuria was suspected and biochemical tests confirmed mild renal impairment, homogentisic acid in urine and homogentisic acid crystal was detected cytologically in urine sediment. Such a case of Alkaptonuric ochronosis with cerebrovascular and renal complications have been rarely reported in the previous literature.

Entities:  

Keywords:  Alkaptonuria; Homogentisic acid; Ochronosis; Renal failure; Stroke

Year:  2010        PMID: 23105912      PMCID: PMC3453108          DOI: 10.1007/s12291-010-0038-6

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  9 in total

1.  Dura mater involvement in ochronosis (alkaptonuria).

Authors:  W Liu; R A Prayson
Journal:  Arch Pathol Lab Med       Date:  2001-07       Impact factor: 5.534

2.  Alkaptonuria: a 60-yr follow-up.

Authors:  R W E Watts; R A Watts
Journal:  Rheumatology (Oxford)       Date:  2006-11-20       Impact factor: 7.580

3.  A 46-year-old man with a 4-year history of diffuse brownish black pigmentation. Endogenous ochronosis (alkaptonuria).

Authors:  G Micali; A G Di Stefano; M R Nasca; M L Musumeci
Journal:  Arch Dermatol       Date:  1998-01

Review 4.  Alkaptonuric ochronosis with aortic valve and joint replacements and femoral fracture: a case report and literature review.

Authors:  Alexander A Fisher; Michael W Davis
Journal:  Clin Med Res       Date:  2004-11

Review 5.  New developments in ochronosis: review of the literature.

Authors:  Julie M Keller; William Macaulay; Ohannes A Nercessian; Israeli A Jaffe
Journal:  Rheumatol Int       Date:  2004-08-21       Impact factor: 2.631

6.  Reversal of clinical symptoms and radiographic abnormalities with protein restriction and ascorbic acid in alkaptonuria.

Authors:  Eva Morava; György Kosztolányi; Udo F H Engelke; Ron A Wevers
Journal:  Ann Clin Biochem       Date:  2003-01       Impact factor: 2.057

7.  Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation.

Authors:  Wendy J Introne; Chanika Phornphutkul; Isa Bernardini; Kevin McLaughlin; Diana Fitzpatrick; William A Gahl
Journal:  Mol Genet Metab       Date:  2002 Sep-Oct       Impact factor: 4.797

8.  Alkaptonuria and renal failure: a case report.

Authors:  Rumeyza Kazancioglu; Ismail Taylan; Fatma Aksak; Haydar Durak; Baki Kumbasar; Mustafa Yenigun; Fuat Sar
Journal:  J Nephrol       Date:  2004 May-Jun       Impact factor: 3.902

9.  Natural history of alkaptonuria.

Authors:  Chanika Phornphutkul; Wendy J Introne; Monique B Perry; Isa Bernardini; Mark D Murphey; Diana L Fitzpatrick; Paul D Anderson; Marjan Huizing; Yair Anikster; Lynn H Gerber; William A Gahl
Journal:  N Engl J Med       Date:  2002-12-26       Impact factor: 91.245

  9 in total
  1 in total

1.  Ochronotic arthritis and ochronotic Achilles tendon rupture in alkaptonuria: A 6 years follow-up case report in China.

Authors:  Lifeng Jiang; Le Cao; Jinghua Fang; Xinning Yu; Xuesong Dai; Xudong Miao
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.